Trans-Sodium Crocetinate

N/A

Report date: 2026/04/29 20:02:18
NME

Base Information

Drug NameTrans-Sodium Crocetinate
Drug Alias NameTSCSodium crocetinateTrans sodium crocetinateTranscrocetinate sodiumTranscrocetin sodium +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOxygen compoundsmodulators
TargetsOxygen compounds
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)HypoxiaIntermittent Claudication +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesRomania
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Virginia
China Registration ClassN/A

Develop Information

Active CompaniesDiffusion Pharmaceuticals Inc
Inactive CompaniesUniversity Of Virginia
Active IndicationsHypoxia
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Intermittent ClaudicationStroke +[6] 

Other Information

ATC CodeN/A
Related LinksWikipedia